Global spread of tigecycline-resistant bacteria: a growing public health concern
Peer-Reviewed Publication
Updates every hour. Last Updated: 19-Jun-2026 08:15 ET (19-Jun-2026 12:15 GMT/UTC)
A new study published in Engineering reveals the global spread of tmexCD1-toprJ1-positive Klebsiella pneumoniae, highlighting its multidrug resistance and transmission across ecological niches. The research underscores the urgent need for antimicrobial stewardship and continuous monitoring to combat this emerging public health threat.
A new study finds that since 2013, expansive growth has been seen in affiliations between fertility clinics and private equity firms, and that over half of IVF cycles in the country in 2023 were done at clinics affiliated with private equity firms.
Hong Kong, China, December 30, 2025 --- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed on the Hong Kong Stock Exchange today, becoming the first AI-driven biotech company to go public in Main Board under Chapter 8.05 listing rules of the HKEX. This initial public offering (IPO) raised a total of HKD 2.277 billion, achieving the largest biotech IPO in Hong Kong this year, as in the size of fundraising.